IN Senate Committee Votes to Restrict Medical Abortion Pill
Yesterday, the Indiana Senate health committee voted 5 to 4 to further restrict women's access to RU-486, or the abortion pill. If the bill passes, doctors would be required to conduct an in-person examination of a woman before prescribing the abortion pill, as well as give her written information of the risks of an abortion and perform a follow-up ultrasound two weeks later. Doctors who fail to comply could face misdemeanor charges.
The bill also requires that doctors follow FDA guidelines recommending that doctors prescribe a 600 milligram dose of the drug, even though studies have found 200 milligrams of the drug to be adequate. Dr. John Stutsman, medical director of Planned Parenthood of Indiana and a professor at Indiana University, indicated that the higher dosage would increase the possibility of side effects for the woman.
The Associated Press reports that mifepristone is currently used in about 15 percent of abortions in the United States. Marketed as Mifeprex in the United States, the drug provides women with more privacy than a surgical procedure does because women are able to take the pill home. Mifepristone has also increased the accessibility of abortion. Among Planned Parenthood's 322 clinics nationwide that provide abortion, almost half administer mifepristone, but do not offer surgery.
Media Resources: National Partnership for Women and Families 1/26/12; Associated Press 1/25/12; Feminist Daily Newswire 9/27/10
10/9/2015 Federal Judge Orders Anti-Abortion Group to Cede Footage to NAF - On Tuesday, a federal judge ruled that anti-abortion group Center for Medical Progress (CMP) and its leader David Daleidan must turn over all previously unreleased "sting" videos and outtakes of National Abortion Federation (NAF) meetings the group obtained surreptitiously as part of a smear campaign against the abortion provider.
U.S. . . .
10/9/2015 Women Scientists Receive Less Funding Than Their Male Peers, Study Finds - According to a new study published by the Journal of the American Medical Association, male scientists receive twice as much financial support to kickstart their careers in science and medicine as their female counterparts, an early career inequity that could limit professional opportunities for women scientists throughout their working lives.
Conducted by Health Resources in Action (HRiA), analysts studied 219 biomedical researchers who had applied for early-career grant funding at 55 New England hospitals, universities and research facilities between 2012 and 2014. . . .
10/7/2015 Study Finds US Gender Wage Gap Persists - Data compiled by the US Census Bureau this week once again demonstrates a gender wage gap, showing that American women who work full-time, year-round jobs on average earn 79 cents for every dollar paid to men. . . .